Quick Answer
Editas Medicine, Inc. reported Operating Income Loss of -$160.01 million for the year ending 2025.
- Editas Medicine, Inc. showed an increase of +36.3% in Operating Income Loss from 2024 to 2025.
- This data is from Editas Medicine, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$5.16 million | Q2 2015: -$10.40 million | Q3 2015: -$7.38 million | Q1 2016: -$17.84 million | Q2 2016: -$19.20 million | Q3 2016: -$21.17 million | Q1 2017: -$30.63 million | Q2 2017: -$26.12 million | Q3 2017: -$26.75 million | Q1 2018: -$31.56 million | Q2 2018: -$39.66 million | Q3 2018: -$16.26 million | Q4 2018: -$26.25 million | Q1 2019: -$31.26 million | Q2 2019: -$35.65 million | Q3 2019: -$34.59 million | Q1 2020: -$46.62 million | Q2 2020: -$31.34 million | Q3 2020: $8.99 million | Q1 2021: -$56.88 million | Q2 2021: -$55.40 million | Q3 2021: -$39.25 million | Q1 2022: -$50.75 million | Q2 2022: -$54.23 million | Q3 2022: -$57.52 million | Q1 2023: -$50.96 million | Q2 2023: -$44.09 million | Q3 2023: -$50.16 million | Q1 2024: -$66.99 million | Q2 2024: -$71.90 million | Q3 2024: -$65.67 million | Q1 2025: -$76.16 million | Q2 2025: -$51.54 million | Q3 2025: -$24.55 million.
- Over the full 12 years of available data (2014 to 2025), Editas Medicine, Inc.'s Operating Income Loss has declined by 1,157.6%.
- Historical annual values: Fiscal year 2025: -$160.01 million | Fiscal year 2024: -$251.15 million | Fiscal year 2023: -$169.18 million | Fiscal year 2022: -$225.95 million | Fiscal year 2021: -$193.15 million | Fiscal year 2020: -$134.84 million | Fiscal year 2019: -$140.92 million | Fiscal year 2018: -$113.73 million | Fiscal year 2017: -$119.93 million | Fiscal year 2016: -$97.19 million | Fiscal year 2015: -$35.31 million | Fiscal year 2014: -$12.72 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: